{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:04:07Z","timestamp":1790759047589,"version":"4.1.0"},"reference-count":223,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>COVID-19 is characterized by virus-induced injury leading to multi-organ failure, together with inflammatory reaction, endothelial cell (EC) injury, and prothrombotic coagulopathy with thrombotic events. Complement system (C)<jats:italic>via<\/jats:italic>its cross-talk with the contact and coagulation systems contributes significantly to the severity and pathological consequences due to SARS-CoV-2 infection. These immunopathological mechanisms overlap in COVID-19 and pre-eclampsia (PE). Thus, mothers contracting SARS-CoV-2 infection during pregnancy are more vulnerable to developing PE. SARS-CoV-2 infection of ECs,<jats:italic>via<\/jats:italic>its receptor ACE2 and co-receptor TMPRSS2, can provoke endothelial dysfunction and disruption of vascular integrity, causing hyperinflammation and hypercoagulability. This is aggravated by bradykinin increase due to inhibition of ACE2 activity by the virus. C is important for the progression of normal pregnancy, and its dysregulation can impact in the form of PE-like syndrome as a consequence of SARS-CoV-2 infection. Thus, there is also an overlap between treatment regimens of COVID-19 and PE. C inhibitors, especially those targeting C3 or MASP-2, are exciting options for treating COVID-19 and consequent PE. In this review, we examine the role of C, contact and coagulation systems as well as endothelial hyperactivation with respect to SARS-CoV-2 infection during pregnancy and likely development of PE.<\/jats:p>","DOI":"10.3389\/fimmu.2021.775168","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T08:25:02Z","timestamp":1637137502000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["COVID-19, Pre-Eclampsia, and Complement System"],"prefix":"10.3389","volume":"12","author":[{"given":"Chiara","family":"Agostinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mangogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Balduit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azin","family":"Aghamajidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus From Patients With Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease-2019 (COVID-19): The Epidemic and the Challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.07.002","article-title":"A Comparison of Mortality-Related Risk Factors of COVID-19, SARS, and MERS: A Systematic Review and Meta-Analysis","volume":"81","author":"Lu","year":"2020","journal-title":"J Infect"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus Infections-More Than Just the Common Cold","volume":"323","author":"Paules","year":"2020","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.03.022","article-title":"Genotype and Phenotype of COVID-19: Their Roles in Pathogenesis","volume":"54","author":"Mousavizadeh","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.07.091","article-title":"Renin-Angiotensin-Aldosterone (RAAS): The Ubiquitous System for Homeostasis and Pathologies","volume":"94","author":"Patel","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2762","article-title":"Structural Basis for the Recognition of SARS-CoV-2 by Full-Length Human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110089","article-title":"EMMPRIN\/BASIGIN as a Biological Modulator of Oral Cancer and COVID-19 Interaction: Novel Propositions","volume":"143","author":"Varadarajan","year":"2020","journal-title":"Med Hypotheses"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103104","article-title":"Persistence of Viral RNA, Pneumocyte Syncytia and Thrombosis Are Hallmarks of Advanced COVID-19 Pathology","volume":"61","author":"Bussani","year":"2020","journal-title":"EBioMedicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/cells10030503","article-title":"Assembly and Cellular Exit of Coronaviruses: Hijacking an Unconventional Secretory Pathway From the Pre-Golgi Intermediate Compartment via the Golgi Ribbon to the Extracellular Space","volume":"10","author":"Saraste","year":"2021","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary Manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2021.1898790","article-title":"Immune Dysregulation and System Pathology in COVID-19","volume":"12","author":"Jamal","year":"2021","journal-title":"Virulence"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune Response, Inflammation, and the Clinical Spectrum of COVID-19","volume":"11","author":"Garcia","year":"2020","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.01.021","article-title":"Activation of the Complement System in Normal Pregnancy and Preeclampsia","volume":"47","author":"Derzsy","year":"2010","journal-title":"Mol Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molimm.2005.06.017","article-title":"The Complement System in the Pathophysiology of Pregnancy","volume":"43","author":"Girardi","year":"2006","journal-title":"Mol Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of Two Parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3858","article-title":"Novel Mechanisms and Functions of Complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.12688\/f1000research.10065.1","article-title":"The Complement System: An Evolution in Progress","volume":"5","author":"Ghebrehiwet","year":"2016","journal-title":"F1000Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement System Part I - Molecular Mechanisms of Activation and Regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1616998114","article-title":"Structure and Activation of C1, the Complex Initiating the Classical Pathway of the Complement Cascade","volume":"114","author":"Mortensen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00592","article-title":"C1 Complex: An Adaptable Proteolytic Module for Complement and Non-Complement Functions","volume":"8","author":"Lu","year":"2017","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of Complement Activation and Regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00149","article-title":"New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System","volume":"17","author":"Ehrnthaller","year":"2011","journal-title":"Mol Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A Journey Through the Lectin Pathway of Complement-MBL and Beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100280","article-title":"The Role of Mannose-Binding Lectin-Associated Serine Protease-3 in Activation of the Alternative Complement Pathway","volume":"187","author":"Iwaki","year":"2011","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202588109","article-title":"Revised Mechanism of Complement Lectin-Pathway Activation Revealing the Role of Serine Protease MASP-1 as the Exclusive Activator of MASP-2","volume":"109","author":"Heja","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","article-title":"Complement and Its Role in Innate and Adaptive Immune Responses","volume":"20","author":"Dunkelberger","year":"2010","journal-title":"Cell Res"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.132.3.1430","article-title":"Characterization of the Initial C3 Convertase of the Alternative Pathway of Human Complement","volume":"132","author":"Fishelson","year":"1984","journal-title":"J\u00a0Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.06.002","article-title":"Properdin in Complement Activation and Tissue Injury","volume":"56","author":"Lesher","year":"2013","journal-title":"Mol Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of Two Parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.1.185","article-title":"Cytolytically Inactive Terminal Complement Complex Causes Transendothelial Migration of Polymorphonuclear Leukocytes In Vitro and In Vivo","volume":"99","author":"Dobrina","year":"2002","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00281-017-0663-8","article-title":"Diseases of Complement Dysregulation-An Overview","volume":"40","author":"Wong","year":"2018","journal-title":"Semin Immunopathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00794","article-title":"Patterns of C1-Inhibitor\/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients","volume":"11","author":"Kajdacsi","year":"2020","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.01.009","article-title":"The Control of the Complement Lectin Pathway Activation Revisited: Both C1-Inhibitor and Antithrombin Are Likely Physiological Inhibitors, While Alpha2-Macroglobulin Is Not","volume":"54","author":"Parej","year":"2013","journal-title":"Mol Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.11.1609","article-title":"Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway","volume":"194","author":"Jiang","year":"2001","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2418-4","article-title":"Complement Factor H in Host Defense and Immune Evasion","volume":"74","author":"Parente","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.148.4.1044","article-title":"Human C4-Binding Protein. II. Role in Proteolysis of C4b by C3b-Inactivator","volume":"148","author":"Fujita","year":"1978","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.153.5.1138","article-title":"Complement Receptor Is an Inhibitor of the Complement Cascade","volume":"153","author":"Iida","year":"1981","journal-title":"J Exp Med"},{"key":"B42","article-title":"Structure and Function of Decay Accelerating Factor CD55","volume":"123","author":"Nicholson-Weller","year":"1994","journal-title":"J Lab Clin Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.09.040191.002243","article-title":"Membrane Cofactor Protein (MCP or CD46): Newest Member of the Regulators of Complement Activation Gene Cluster","volume":"9","author":"Liszewski","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/1-4020-8056-5_6","article-title":"Terminal Complement Complex: Regulation of Formation and Pathophysiological Functions","volume-title":"The Complement System: Novel Roles in Health and Disease","author":"Tedesco","year":"2004"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/BF01837366","article-title":"Membrane Proteins That Protect Against Complement Lysis","volume":"15","author":"Morgan","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1042\/bj2310205","article-title":"The Recovery of Human Polymorphonuclear Leucocytes From Sublytic Complement Attack Is Mediated by Changes in Intracellular Free Calcium","volume":"231","author":"Morgan","year":"1985","journal-title":"Biochem J"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-242693","article-title":"Sublytic C5b-9 Induces IL-6 and TGF-Beta1 Production by Glomerular Mesangial Cells in Rat Thy-1 Nephritis Through P300-Mediated C\/EBPbeta Acetylation","volume":"28","author":"Zhang","year":"2014","journal-title":"FASEB J"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.120.6.1841","article-title":"The C5b-6 Complex: Formation, Isolation, and Inhibition of Its Activity by Lipoprotein and the S-Protein of Human Serum","volume":"120","author":"Podack","year":"1978","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113531","article-title":"SP-40,40, a Newly Identified Normal Human Serum Protein Found in the SC5b-9 Complex of Complement and in the Immune Deposits in Glomerulonephritis","volume":"81","author":"Murphy","year":"1988","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/v13050824","article-title":"Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses","volume":"13","author":"Murugaiah","year":"2021","journal-title":"Viruses"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01450","article-title":"Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics","volume":"11","author":"Mellors","year":"2020","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070166","article-title":"The Role of Complement in Inflammatory Diseases From Behind the Scenes Into the Spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am J Pathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/0-387-34134-X_6","article-title":"Self, Non-Self, and Danger: A Complementary View","volume":"586","author":"K\u00f6hl","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2011.07.016","article-title":"The New Face of Anaphylatoxins in Immune Regulation","volume":"217","author":"Zhou","year":"2012","journal-title":"Immunobiology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01117","article-title":"Complement Evasion Strategies of Viruses: An Overview","volume":"8","author":"Agrawal","year":"2017","journal-title":"Front Microbiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/v13020208","article-title":"Virus-Encoded Complement Regulators: Current Status","volume":"13","author":"Sinha","year":"2021","journal-title":"Viruses"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.13856","article-title":"The Imitation Game: A Viral Strategy to Subvert the Complement System","volume":"594","author":"Agrawal","year":"2020","journal-title":"FEBS Lett"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The Case of Complement Activation in COVID-19 Multiorgan Impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.714511","article-title":"Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins","volume":"12","author":"Ali","year":"2021","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008248","article-title":"Direct Activation of the Alternative Complement Pathway by SARS-CoV-2 Spike Proteins Is Blocked by Factor D Inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/biomedicines9081003","article-title":"Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients","volume":"9","author":"Macor","year":"2021","journal-title":"Biomedicines"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.29.20041962","article-title":"Highly Pathogenic Coronavirus N Protein Aggravates Lung Injury by MASP-2-Mediated Complement Over-Activation","author":"Gao","year":"2020","journal-title":"medRxiv"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0320-7","article-title":"Complement as a Target in COVID-19","volume":"20","author":"Risitano","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 Inflammation With Activation of the C5a-C5aR1 Axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S284830","article-title":"Complement Inhibition and COVID-19: The Story So Far","volume":"10","author":"Fodil","year":"2021","journal-title":"Immunotargets Ther"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000644","article-title":"COVID-19: Complement, Coagulation, and Collateral Damage","volume":"205","author":"Lo","year":"2020","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e140711","DOI":"10.1172\/jci.insight.140711","article-title":"The Complement System in COVID-19: Friend and Foe","volume":"5","author":"Java","year":"2020","journal-title":"JCI Insight"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048959","article-title":"Complement Cascade in Severe Forms of COVID-19: Recent Advances in Therapy","volume":"51","author":"Chouaki Benmansour","year":"2021","journal-title":"Eur J Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2019.12.001","article-title":"An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates","volume":"37","author":"Goveia","year":"2020","journal-title":"Cancer Cell"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2020.10.005","article-title":"COVID-19 - A Vascular Disease","volume":"31","author":"Siddiqi","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 Is, in the End, an Endothelial Disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur Heart J"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: The Vasculature Unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00548.2020","article-title":"Kinins and Chymase: The Forgotten Components of the Renin-Angiotensin System and Their Implications in COVID-19 Disease","volume":"320","author":"Abassi","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/ph13090215","article-title":"Kinins and Their Receptors in Infectious Diseases","volume":"13","author":"Dagnino","year":"2020","journal-title":"Pharmaceut (Basel)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12159","article-title":"ACE2, Angiotensin-(1-7) and Mas Receptor Axis in Inflammation and Fibrosis","volume":"169","author":"Simoes e Silva","year":"2013","journal-title":"Br J Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41581-020-00357-4","article-title":"Immunity, Endothelial Injury and Complement-Induced Coagulopathy in COVID-19","volume":"17","author":"Perico","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140183","article-title":"COVID-19, Microangiopathy, Hemostatic Activation, and Complement","volume":"130","author":"Song","year":"2020","journal-title":"J Clin Invest"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement Associated Microvascular Injury and Thrombosis in the Pathogenesis of Severe COVID-19 Infection: A Report of Five Cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13166","article-title":"Blood Clotting and Traumatic Injury With Shock Mediates Complement-Dependent Neutrophil Priming for Extracellular ROS, ROS-Dependent Organ Injury and Coagulopathy","volume":"194","author":"Barrett","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 Patients in Intensive Care Unit: A Report of Thromboelastography Findings and Other Parameters of Hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B81","doi-asserted-by":"publisher","first-page":"eabj1014","DOI":"10.1126\/sciimmunol.abj1014","article-title":"Complement Control for COVID-19","volume":"6","author":"Bosmann","year":"2021","journal-title":"Sci Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.02.006","article-title":"Complement and Coagulation: Strangers or Partners in Crime","volume":"28","author":"Markiewski","year":"2007","journal-title":"Trends Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrneph.2015.177","article-title":"The Emerging Role of Coagulation Proteases in Kidney Disease","volume":"12","author":"Madhusudhan","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2017.07.009","article-title":"The Plasma Contact System, a Protease Cascade at the Nexus of Inflammation, Coagulation and Immunity","volume":"1864","author":"Weidmann","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-78952-1_6","article-title":"Interaction Between the Coagulation and Complement System","volume":"632","author":"Amara","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/rth2.12235","article-title":"Factor XII - What\u2019s Important But Not Commonly Thought About","volume":"3","author":"Schmaier","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02046","article-title":"Plasminflammation-An Emerging Pathway to Bradykinin Production","volume":"10","author":"Maas","year":"2019","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1177\/1535370220978372","article-title":"Protease-Activated Receptor 1 as a Potential Therapeutic Target for COVID-19","volume":"246","author":"Rovai","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.21037\/cdt.2018.10.14","article-title":"Tissue Factor: Newer Concepts in Thrombosis and Its Role Beyond Thrombosis and Hemostasis","volume":"8","author":"Cimmino","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-5890(99)90054-8","article-title":"Complement-Endothelial Cell Interactions: Pathophysiological Implications","volume":"36","author":"Tedesco","year":"1999","journal-title":"Mol Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.9.1619","article-title":"The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.6.1807","article-title":"Complement-Mediated Regulation of Tissue Factor Activity in Endothelium","volume":"182","author":"Saadi","year":"1995","journal-title":"J Exp Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A Novel C5a Receptor-Tissue Factor Cross-Talk in Neutrophils Links Innate Immunity to Coagulation Pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10-460493","article-title":"Rapid Activation of Monocyte Tissue Factor by Antithymocyte Globulin Is Dependent on Complement and Protein Disulfide Isomerase","volume":"121","author":"Langer","year":"2013","journal-title":"Blood"},{"key":"B95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 Infection Associated With Endothelial Activation","volume":"190","author":"Escher","year":"2020","journal-title":"Thromb Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial Cell Infection and Endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"B97","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and Genetics of Von Willebrand Factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14976","article-title":"Von Willebrand Factor and Cancer; Metastasis and Coagulopathies","volume":"18","author":"Patmore","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)81901-9","article-title":"Complement Proteins C5b-9 Induce Secretion of High Molecular Weight Multimers of Endothelial Von Willebrand Factor and Translocation of Granule Membrane Protein GMP-140 to the Cell Surface","volume":"264","author":"Hattori","year":"1989","journal-title":"J Biol Chem"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)39666-8","article-title":"Complement Proteins C5b-9 Induce Vesiculation of the Endothelial Plasma Membrane and Expose Catalytic Surface for Assembly of the Prothrombinase Enzyme Complex","volume":"265","author":"Hamilton","year":"1990","journal-title":"J\u00a0Biol Chem"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.302280","article-title":"Human Complement Factor H Is a Reductase for Large Soluble Von Willebrand Factor Multimers\u2013Brief Report","volume":"33","author":"Nolasco","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-Associated Coagulopathy: Evidence From a Single-Centre, Cross-Sectional Study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000267878.97021.ab","article-title":"Adhesion Mechanisms in Platelet Function","volume":"100","author":"Ruggeri","year":"2007","journal-title":"Circ Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276311","article-title":"Von Willebrand Factor Promotes Leukocyte Extravasation","volume":"116","author":"Petri","year":"2010","journal-title":"Blood"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)83104-0","article-title":"Stimulated Secretion of Endothelial Von Willebrand Factor Is Accompanied by Rapid Redistribution to the Cell Surface of the Intracellular Granule Membrane Protein GMP-140","volume":"264","author":"Hattori","year":"1989","journal-title":"J Biol Chem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445070","article-title":"TFPI Inhibits Lectin Pathway of Complement Activation by Direct Interaction With MASP-2","volume":"45","author":"Keizer","year":"2015","journal-title":"Eur J Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)81346-7","article-title":"Complement Proteins C5b-9 Cause Release of Membrane Vesicles From the Platelet Surface That Are Enriched in the Membrane Receptor for Coagulation Factor Va and Express Prothrombinase Activity","volume":"263","author":"Sims","year":"1988","journal-title":"J Biol Chem"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular Intercommunication Between the Complement and Coagulation Systems","volume":"185","author":"Amara","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1358\/dnp.2004.17.7.863703","article-title":"Biological Effects of C1 Inhibitor","volume":"17","author":"Davis","year":"2004","journal-title":"Drug News Perspect"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1021\/bi00403a018","article-title":"Inhibition of Human Blood Coagulation Factor XIa by C-1 Inhibitor","volume":"27","author":"Meijers","year":"1988","journal-title":"Biochemistry"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200106000-00005","article-title":"In Vitro Interaction of C1-Inhibitor With Thrombin","volume":"12","author":"Cugno","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16938","article-title":"C1 Esterase Inhibitor and the Contact System in COVID-19","volume":"190","author":"Thomson","year":"2020","journal-title":"Br J Haematol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-00972-1","article-title":"C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19","volume":"41","author":"Adesanya","year":"2021","journal-title":"J Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and Metabolomic Characterization of COVID-19 Patient Sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"key":"B115","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.thromres.2016.07.017","article-title":"Thrombomodulin Enhances Complement Regulation Through Strong Affinity Interactions With Factor H and C3b-Factor H Complex","volume":"145","author":"Heurich","year":"2016","journal-title":"Thromb Res"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement Activation in Arterial and Venous Thrombosis Is Mediated by Plasmin","volume":"5","author":"Foley","year":"2016","journal-title":"EBioMedicine"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2002.tb02669.x","article-title":"Inactivation of C3a and C5a Octapeptides by Carboxypeptidase R and Carboxypeptidase N","volume":"46","author":"Campbell","year":"2002","journal-title":"Microbiol Immunol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic State and High Thrombin Generation may Play a Major Role in SARS-COV2 Associated Thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.03.244","article-title":"Complement and Platelets: Mutual Interference in the Immune Network","volume":"67","author":"Speth","year":"2015","journal-title":"Mol Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00131","article-title":"Platelets and Complement Cross-Talk in Early Atherogenesis","volume":"6","author":"Kim","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The Role of the Anaphylatoxins in Health and Disease","volume":"46","author":"Klos","year":"2009","journal-title":"Mol Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.2.603","article-title":"Human Platelet Activation by C3a and C3a Des-Arg","volume":"158","author":"Polley","year":"1983","journal-title":"J Exp Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041497","article-title":"Platelet Activation Leads to Activation and Propagation of the Complement System","volume":"201","author":"Del Conde","year":"2005","journal-title":"J Exp Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601121","article-title":"Interaction Between Multimeric Von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis","volume":"199","author":"Bettoni","year":"2017","journal-title":"J Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.4.875.875","article-title":"Complement Proteins C5b-9 Stimulate Procoagulant Activity Through Platelet Prothrombinase","volume":"68","author":"Wiedmer","year":"1986","journal-title":"Blood"},{"key":"B126","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-Eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-016-0689-8","article-title":"Hypertensive Disorders of Pregnancy","volume":"63","author":"Sjaus","year":"2016","journal-title":"Can J Anaesth"},{"key":"B128","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2393-9-8","article-title":"The HELLP Syndrome: Clinical Issues and Management. A Review","volume":"9","author":"Haram","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: Making Sense of Pre-Eclampsia - Two Placental Causes of Preeclampsia","author":"Redman","year":"2014","journal-title":"Placenta"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l2381","article-title":"Pre-Eclampsia: Pathophysiology and Clinical Implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.09.015","article-title":"VE-Cadherin Is a Critical Molecule for Trophoblast-Endothelial Cell Interaction in Decidual Spiral Arteries","volume":"303","author":"Bulla","year":"2005","journal-title":"Exp Cell Res"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903215","article-title":"An Alternative Role of C1q in Cell Migration and Tissue Remodeling: Contribution to Trophoblast Invasion and Placental Development","volume":"185","author":"Agostinis","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.3390\/nu12061822","article-title":"Zinc Oxide Exerts Anti-Inflammatory Properties on Human Placental Cells","volume":"12","author":"Balduit","year":"2020","journal-title":"Nutrients"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1191\/0961203304lu2010oa","article-title":"Feto-Maternal Immune Interaction at the Placental Level","volume":"13","author":"Bulla","year":"2004","journal-title":"Lupus"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-015-2069-x","article-title":"Morphological Changes of Placental Syncytium and Their Implications for the Pathogenesis of Preeclampsia","volume":"73","author":"Roland","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1080\/0891693031000067331","article-title":"Placental Trophoblast and Endothelial Cells as Target of Maternal Immune Response","volume":"36","author":"Bulla","year":"2003","journal-title":"Autoimmunity"},{"key":"B137","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.mam.2007.02.006","article-title":"The Role of the Immune System in Preeclampsia","volume":"28","author":"Saito","year":"2007","journal-title":"Mol Aspects Med"},{"key":"B138","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/cei.13311","article-title":"Overview of Procalcitonin in Pregnancy and in Pre-Eclampsia","volume":"198","author":"Mangogna","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B139","article-title":"Complement Activation and Anaphylatoxin (C3a and C5a) Formation in Preeclampsia and by Amniotic Fluid","volume":"73","author":"Haeger","year":"1989","journal-title":"Obstet Gynecol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2012.11.006","article-title":"Elevated Complement Factor C5a in Maternal and Umbilical Cord Plasma in Preeclampsia","volume":"97","author":"Denny","year":"2013","journal-title":"J Reprod Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12586","article-title":"Complement Component C1q as Potential Diagnostic But Not Predictive Marker of Preeclampsia","volume":"76","author":"Agostinis","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01420","article-title":"Urinary Excretion of C5b-9 in Severe Preeclampsia: Tipping the Balance of Complement Activation in Pregnancy","volume":"62","author":"Burwick","year":"2013","journal-title":"Hypertension"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.07.044","article-title":"Complement Activation Fragment Bb in Early Pregnancy and Spontaneous Preterm Birth","volume":"199","author":"Lynch","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501361","article-title":"Critical Role and Therapeutic Control of the Lectin Pathway of Complement Activation in an Abortion-Prone Mouse Mating","volume":"195","author":"Petitbarat","year":"2015","journal-title":"J Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00312","article-title":"Complement Activation and Regulation in Preeclamptic Placenta","volume":"5","author":"Lokki","year":"2014","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2009.08.004","article-title":"Early Regulators in Abortion and Implications for a Preeclampsia Model","volume":"82","author":"Chaouat","year":"2009","journal-title":"J\u00a0Reprod Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble Fms-Like Tyrosine Kinase 1 (Sflt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia Among High Risk Pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PloS One"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of Circulating Placental Growth Factor, Vascular Endothelial Growth Factor, Soluble Fms-Like Tyrosine Kinase 1 and Soluble Endoglin in the Prediction of Pre-Eclampsia: A Systematic Review and Meta-Analysis","volume":"119","author":"Kleinrouweler","year":"2012","journal-title":"BJOG"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2017.61","article-title":"Placental Growth Factor and Pre-Eclampsia","volume":"31","author":"Chau","year":"2017","journal-title":"J Hum Hypertens"},{"key":"B151","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ando.2016.04.007","article-title":"Angiogenic Balance (Sflt-1\/PlGF) and Preeclampsia","volume":"77","author":"Lecarpentier","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"B152","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the Sflt-1:PlGF Ratio in Women With Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/1471-2393-14-324","article-title":"Multicenter Prospective Clinical Study to Evaluate the Prediction of Short-Term Outcome in Pregnant Women With Suspected Preeclampsia (PROGNOSIS): Study Protocol","volume":"14","author":"Hund","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13867","article-title":"Maternal and Perinatal Outcomes With COVID-19: A Systematic Review of 108 Pregnancies","volume":"99","author":"Zaigham","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1002\/uog.23628","article-title":"Counseling in Maternal-Fetal Medicine: SARS-CoV-2 Infection in Pregnancy","volume":"57","author":"Di Mascio","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2021.03.012","article-title":"Clinical and Obstetric Characteristics of Pregnant Women With Covid-19: A Case Series Study on 26 Patients","volume":"60","author":"Abedzadeh-Kalahroudi","year":"2021","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30360-3","article-title":"Clinical Characteristics and Intrauterine Vertical Transmission Potential of COVID-19 Infection in Nine Pregnant Women: A Retrospective Review of Medical Records","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.05.011","article-title":"SARS-CoV-2 Infection and COVID-19 During Pregnancy: A Multidisciplinary Review","volume":"95","author":"Narang","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.05.014","article-title":"Preeclampsia and COVID-19: Results From the INTERCOVID Prospective Longitudinal Study","volume":"225","author":"Papageorghiou","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16339","article-title":"Pre-Eclampsia-Like Syndrome Induced by Severe COVID-19: A Prospective Observational Study","volume":"127","author":"Mendoza","year":"2020","journal-title":"BJOG"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.03.001","article-title":"Coronavirus Disease 2019 Infection and Hypertensive Disorders of Pregnancy","volume":"224","author":"Rosenbloom","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gaaa030","article-title":"Potential Influence of COVID-19\/ACE2 on the Female Reproductive System","volume":"26","author":"Jing","year":"2020","journal-title":"Mol Hum Reprod"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14767058.2021.1949704","article-title":"Serum Levels of Soluble FMS-Like Tyrosine Kinase 1 and Endothelial Glycocalyx Components in Early- and Late-Onset Preeclampsia","author":"Kornacki","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-021-09805-6","article-title":"COVID-19 Is a Systemic Vascular Hemopathy: Insight for Mechanistic and Clinical Aspects","volume":"24","author":"Smadja","year":"2021","journal-title":"Angiogenesis"},{"key":"B166","doi-asserted-by":"publisher","first-page":"R182","DOI":"10.1186\/cc9290","article-title":"The Association of Endothelial Cell Signaling, Severity of Illness, and Organ Dysfunction in Sepsis","volume":"14","author":"Shapiro","year":"2010","journal-title":"Crit Care"},{"key":"B167","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/molehr\/gaw077","article-title":"Placental-Specific sFLT-1: Role in Pre-Eclamptic Pathophysiology and Its Translational Possibilities for Clinical Prediction and Diagnosis","volume":"23","author":"Palmer","year":"2017","journal-title":"Mol Hum Reprod"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2014.07.006","article-title":"Increase in Both Angiogenic and Angiostatic Mediators in Patients With Idiopathic Pulmonary Fibrosis","volume":"62","author":"Smadja","year":"2014","journal-title":"Pathol Biol (Paris)"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26037","article-title":"SFLT-1 Levels in COVID-19 Patients: Association With Outcome and Thrombosis","volume":"96","author":"Negro","year":"2021","journal-title":"Am J Hematol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15339","article-title":"Placental Growth Factor Level in Plasma Predicts COVID-19 Severity and in-Hospital Mortality","volume":"19","author":"Smadja","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25882","article-title":"Increased sFLT-1\/PlGF Ratio in COVID-19: A Novel Link to Angiotensin II-Mediated Endothelial Dysfunction","volume":"95","author":"Giardini","year":"2020","journal-title":"Am J Hematol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/1471-0528.16402","article-title":"Re: Pre-Eclampsia-Like Syndrome Induced by Severe Coronavirus Disease 2019: A Prospective Observational Study","volume":"127","author":"Amorim","year":"2020","journal-title":"BJOG"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of Preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cca.2010.09.030","article-title":"Pre-Eclampsia: Relationship Between Coagulation, Fibrinolysis and Inflammation","volume":"412","author":"Dusse","year":"2011","journal-title":"Clin Chim Acta"},{"key":"B175","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cca.2012.10.060","article-title":"Fibrinolytic System in Preeclampsia","volume":"416","author":"Pinheiro","year":"2013","journal-title":"Clin Chim Acta"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia Is Associated With Severe Coronavirus Disease 2019 (COVID-19) Infections: A Meta-Analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1709650","article-title":"D-Dimer Is Associated With Severity of Coronavirus Disease 2019: A Pooled Analysis","volume":"120","author":"Lippi","year":"2020","journal-title":"Thromb Haemost"},{"key":"B178","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected With 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"B180","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/aji.12222","article-title":"Monocytes From Pregnant Women With Pre-Eclampsia Are Polarized to a M1 Phenotype","volume":"72","author":"Medeiros","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"B181","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 Infection: The Role of Cytokines in COVID-19 Disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16584","article-title":"Re: Pre-Eclampsia-Like Syndrome Induced by Severe COVID-19: A Prospective Observational Study: Common Pathophysiology of Pre-Eclampsia and Severe COVID-19","volume":"128","author":"Leavitt","year":"2021","journal-title":"BJOG"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620943293","article-title":"COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response","volume":"26","author":"Jayarangaiah","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2015-000134","article-title":"Placental Histology and Neutrophil Extracellular Traps in Lupus and Pre-Eclampsia Pregnancies","volume":"3","author":"Marder","year":"2016","journal-title":"Lupus Sci Med"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil Extracellular Traps Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"key":"B186","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, Complement, and Coagulation: A Triangular Relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejogrb.2021.06.006","article-title":"Early-Onset Preeclampsia - The Impact of Antiphospholipid Antibodies on Disease Severity","volume":"263","author":"Zemet","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"eabd3876","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic Autoantibodies in Serum From Patients Hospitalized With COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Transl Med"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 Activation Is Required for Antiphospholipid Antibody-Induced Fetal Loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-066043","article-title":"Clinical Significance of Different Antiphospholipid Antibodies in the WAPS (Warfarin in the Antiphospholipid Syndrome) Study","volume":"110","author":"Galli","year":"2007","journal-title":"Blood"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00449","article-title":"Complement in the Pathophysiology of the Antiphospholipid Syndrome","volume":"10","author":"Chaturvedi","year":"2019","journal-title":"Front Immunol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.09.038","article-title":"Complement Activation and Regulation in Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelet Count Syndrome","author":"Burwick","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"e99128","DOI":"10.1172\/jci.insight.99128","article-title":"Germline Mutations in the Alternative Pathway of Complement Predispose to HELLP Syndrome","volume":"3","author":"Vaught","year":"2018","journal-title":"JCI Insight"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108726","article-title":"Genetic Justification of Severe COVID-19 Using a Rigorous Algorithm","volume":"226","author":"Gavriilaki","year":"2021","journal-title":"Clin Immunol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the Prevention of Preterm and Term Preeclampsia: Systematic Review and Metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03098","article-title":"Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia","volume":"10","author":"Pierik","year":"2019","journal-title":"Front Immunol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1543656","article-title":"Prevention of Preeclampsia in High-Risk Patients With Low-Molecular-Weight Heparin: A Meta-Analysis","volume":"33","author":"Wang","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15789","article-title":"Prevention of Pre-Eclampsia by Low-Molecular-Weight Heparin in Addition to Aspirin: A Meta-Analysis","volume":"47","author":"Roberge","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1084\/jem.150.5.1202","article-title":"Surface-Associated Heparin Inhibits Zymosan-Induced Activation of the Human Alternative Complement Pathway by Augmenting the Regulatory Action of the Control Proteins on Particle-Bound C3b","volume":"150","author":"Kazatchkine","year":"1979","journal-title":"J Exp Med"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01365-1","article-title":"Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients With COVID-19","volume":"80","author":"Bianconi","year":"2020","journal-title":"Drugs"},{"key":"B201","unstructured":"Protective Effect of Aspirin on COVID-19 Patients2020"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial","volume":"56","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1720978","article-title":"Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality","volume":"120","author":"Billett","year":"2020","journal-title":"Thromb Haemost"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1128\/iai.40.3.1011-1014.1983","article-title":"Steroids Inhibit Activation of the Alternative-Amplification Pathway of Complement","volume":"40","author":"Packard","year":"1983","journal-title":"Infect Immun"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1128\/iai.38.1.122-126.1982","article-title":"Methylprednisolone Inhibits the Alternative and Amplification Pathways of Complement","volume":"38","author":"Weiler","year":"1982","journal-title":"Infect Immun"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319843343","article-title":"Hydroxychloroquine Treatment During Pregnancy in Lupus Patients Is Associated With Lower Risk of Preeclampsia","volume":"28","author":"Seo","year":"2019","journal-title":"Lupus"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06146-w","article-title":"Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: A Systematic Review and Meta-Analysis","volume":"35","author":"Elavarasi","year":"2020","journal-title":"J Gen Intern Med"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86957","article-title":"Pravastatin Improves Pregnancy Outcomes in Obstetric Antiphospholipid Syndrome Refractory to Antithrombotic Therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"J Clin Invest"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gau019","article-title":"Statins Prevent Cervical Remodeling, Myometrial Contractions and Preterm Labor Through a Mechanism That Involves Hemoxygenase-1 and Complement Inhibition","volume":"20","author":"Gonzalez","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2012.11.014","article-title":"Eculizumab for the Treatment of Preeclampsia\/HELLP Syndrome","volume":"34","author":"Burwick","year":"2013","journal-title":"Placenta"},{"key":"B211","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1186\/s13063-020-04884-0","article-title":"Zilucoplan in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (ZILU-COV): A Structured Summary of a Study Protocol for a Randomised Controlled Trial","volume":"21","author":"Declercq","year":"2020","journal-title":"Trials"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108450","article-title":"The First Case of COVID-19 Treated With the Complement C3 Inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin Immunol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1186\/s13063-020-04548-z","article-title":"A Phase 3 Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared With Best Supportive Care in Patients With COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A Structured Summary of a Study Protocol for a Randomised Controlled Trial","volume":"21","author":"Smith","year":"2020","journal-title":"Trials"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202004_20875","article-title":"Eculizumab Treatment in Patients With COVID-19: Preliminary Results From Real Life ASL Napoli 2 Nord Experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B215","doi-asserted-by":"publisher","first-page":"eabg0833","DOI":"10.1126\/sciimmunol.abg0833","article-title":"SARS-CoV-2 Drives JAK1\/2-Dependent Local Complement Hyperactivation","volume":"6","author":"Yan","year":"2021","journal-title":"Sci Immunol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2020.152001","article-title":"Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment With the Lectin-Pathway Inhibitor Narsoplimab","volume":"225","author":"Rambaldi","year":"2020","journal-title":"Immunobiology"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108598","article-title":"Complement C3 vs C5 Inhibition in Severe COVID-19: Early Clinical Findings Reveal Differential Biological Efficacy","volume":"220","author":"Mastellos","year":"2020","journal-title":"Clin Immunol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and Viral Pathogenesis","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100590","article-title":"Eculizumab as an Emergency Treatment for Adult Patients With Severe COVID-19 in the Intensive Care Unit: A Proof-of-Concept Study","volume":"28","author":"Annane","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30341-6","article-title":"Anti-C5a Antibody IFX-1 (Vilobelimab) Treatment Versus Best Supportive Care for Patients With Severe COVID-19 (PANAMO): An Exploratory, Open-Label, Phase 2 Randomised Controlled Trial","volume":"2","author":"Vlaar","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"B221","unstructured":"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia (FORCE)2020"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1172\/JCI141374","article-title":"Complement and Tissue Factor-Enriched Neutrophil Extracellular Traps Are Key Drivers in COVID-19 Immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02072","article-title":"Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System","volume":"11","author":"Urwyler","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.775168\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T13:21:28Z","timestamp":1673788888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.775168\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":223,"alternative-id":["10.3389\/fimmu.2021.775168"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.775168","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"article-number":"775168"}}